Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Meta Platforms (Facebook)
META
|
+$742M |
| 3 |
Wells Fargo
WFC
|
+$363M |
| 4 |
Salesforce
CRM
|
+$310M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$869M |
| 2 |
Apple
AAPL
|
+$693M |
| 3 |
PPLI
People Inc
PPLI
|
+$488M |
| 4 |
Expedia Group
EXPE
|
+$409M |
| 5 |
Charter Communications
CHTR
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.96% |
| 2 | Healthcare | 2.64% |
| 3 | Financials | 2.22% |
| 4 | Consumer Discretionary | 2.1% |
| 5 | Industrials | 1.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
6751
PUT
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $622K | ﹤0.01% |
45,700
-35,900
| -44% | -$553K |
|
|
GDVD
6752
DELISTED
Principal Active Global Dividend Income ETF
GDVD
| $622K | ﹤0.01% |
+21,888
| New | +$613K |
|
6753
CALL
First American
FAF
$7.37B
| $621K | ﹤0.01% |
12,200
+8,000
| +190% | +$414K |
|
6754
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.59B
| $621K | ﹤0.01% |
34,838
-3,995
| -10% | -$73.9K |
|
6755
Primis Financial Corp
FRST
$402M
| $621K | ﹤0.01% |
71,513
+145
| +0.2% | +$1.27K |
|
|
VBIV
6756
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $621K | ﹤0.01% |
7,233
+5,503
| +318% | +$641K |
|
|
TNAV
6757
DELISTED
Telenav Inc.
TNAV
| $621K | ﹤0.01% |
172,526
+124,269
| +258% | +$603K |
|
|
AMAG
6758
CALL
DELISTED
AMAG Pharmaceuticals
AMAG
| $621K | ﹤0.01% |
66,100
+24,000
| +57% | +$228K |
|
6759
PUT
Tucows
TCX
$142M
| $620K | ﹤0.01% |
9,000
-15,700
| -64% | -$1.02M |
|
6760
Columbia Financial
CLBK
$1.12B
| $619K | ﹤0.01% |
55,746
+45,226
| +430% | +$535K |
|
6761
CALL
Dr. Reddy's Laboratories
RDY
$10.1B
| $619K | ﹤0.01% |
44,500
+21,000
| +89% | +$250K |
|
6762
Innovator US Equity Ultra Buffer ETF August
UAUG
$180M
| $619K | ﹤0.01% |
22,912
-55,183
| -71% | -$1.48M |
|
6763
Alphatec Holdings
ATEC
$1.47B
| $618K | ﹤0.01% |
93,014
+36,691
| +65% | +$207K |
|
6764
PUT
Fabrinet
FN
$18.9B
| $618K | ﹤0.01% |
9,800
+700
| +8% | +$47K |
|
6765
State Street SPDR S&P Health Care Services ETF
XHS
$210M
| $618K | ﹤0.01% |
7,985
+2,892
| +57% | +$217K |
|
6766
PUT
Antero Midstream
AM
$10.4B
| $617K | ﹤0.01% |
114,900
-21,600
| -16% | -$132K |
|
|
EVOK
6767
CALL
DELISTED
Evoke Pharma
EVOK
| $617K | ﹤0.01% |
+913
| New | +$582K |
|
6768
PUT
Monro
MNRO
$368M
| $617K | ﹤0.01% |
15,200
+7,500
| +97% | +$383K |
|
6769
PUT
Invesco DB Oil Fund
DBO
$390M
| $616K | ﹤0.01% |
85,700
-5,400
| -6% | -$39.8K |
|
6770
Regional Management Corp
RM
$291M
| $616K | ﹤0.01% |
36,931
-19,732
| -35% | -$339K |
|
|
SRNE
6771
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $616K | ﹤0.01% |
55,278
-364,991
| -87% | -$3.34M |
|
6772
InfuSystem Holdings
INFU
$241M
| $615K | ﹤0.01% |
47,971
+35,453
| +283% | +$461K |
|
6773
PUT
Medpace
MEDP
$16.8B
| $615K | ﹤0.01% |
5,500
-9,100
| -62% | -$1.05M |
|
6774
Prudential
PUK
$35.1B
| $615K | ﹤0.01% |
22,176
+10,179
| +85% | +$305K |
|
6775
Rhythm Pharmaceuticals
RYTM
$7.95B
| $615K | ﹤0.01% |
+28,398
| New | +$651K |
|
Similar funds
Citadel Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Citadel Advisors held 11,253 positions worth $353B, up 26% from $280B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Citadel Advisors deployed $24.6B of net new capital in Q3 2020, opening 1,597 new positions and adding to 4,071 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.3% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Amazon, an estimated $869M trimmed.
- Citadel Advisors's largest Q3 2020 buy was iShares MSCI EAFE ETF: 4,016,602 shares worth $256M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $1.04B increase.
- Citadel Advisors's biggest Q3 2020 reduction was Amazon, cutting an estimated $869M.
- Citadel Advisors fully exited Intel in Q3 2020, selling an estimated $249M.
- Citadel Advisors's ten largest holdings make up 36% of its $353B portfolio in Q3 2020.
- Citadel Advisors opened 1,597 new positions and closed 1,264 in Q3 2020.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $353B.
Based on Citadel Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.